Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 24 of 1714:
14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CARVEDILOL Calcium Channel Type L, Phenylalkylamine 95% .389uM .378uM View
calcium channel, voltage-dependent, gamma subunit 8 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 7 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 6 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 5 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 4 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 3 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 2 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 1 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, beta 4 subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, beta 3 subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, beta 2 subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, alpha 1F subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type IV, beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type IV, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type III, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type II, beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type II, alpha 2 TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type I, beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type I, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
adrenergic receptor, alpha 2a TERCONAZOLE Adrenergic alpha2A 95% .983uM .369uM View
sodium channel, voltage-gated, type IV, beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel associated protein 1 TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel associated protein 2 TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type III, beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type I, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type IX, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type VII, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
amiloride-sensitive cation channel 5, intestinal TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type III, beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type XI, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type I, beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type 10, alpha polypeptide TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type IV, alpha polypeptide TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type V, alpha polypeptide TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type II, beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, nonvoltage-gated 1 alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, nonvoltage-gated 1 gamma TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
monoamine oxidase A PENTAMIDINE Monoamine Oxidase MAOA 95% .793uM NoneNone View
monoamine oxidase A PENTAMIDINE Monoamine Oxidase MAOA 95% .793uM NoneNone View
dopamine receptor D1A PROCHLORPERAZINE Dopamine D1 95% .155uM .078uM View
5-hydroxytryptamine (serotonin) receptor 2C ERGOTAMINE Serotonin 5-HT2C 96% .056uM .029uM View
sodium channel, nonvoltage-gated 1 alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, nonvoltage-gated 1 gamma DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, nonvoltage-gated 1 beta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type XI, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, nonvoltage-gated 1, gamma DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, nonvoltage-gated 1, delta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, nonvoltage-gated 1 alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type X, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type IX, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage gated, type VIII, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type VII, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
calcium channel, voltage-dependent, beta 4 subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, beta 3 subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, beta 2 subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, alpha 1F subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, beta 1 subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 NISOLDIPINE Calcium Channel Type L, Dihydropyridine 95% .000741uM .000476uM View
prostaglandin-endoperoxide synthase 1 NIMESULIDE Cyclooxygenase COX-1 95% 1.226uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) NIMESULIDE Cyclooxygenase COX-1 95% 1.226uM NoneNone View
histamine receptor H 2 ASTEMIZOLE Histamine H2 95% 1.682uM 1.654uM View
adrenergic receptor, alpha 2b CLOMIPHENE Adrenergic alpha2C 95% 1.482uM .215uM View
adrenergic receptor, alpha 2c (Non-specific probe) CLOMIPHENE Adrenergic alpha2C 95% 1.482uM .215uM View
cholinergic receptor, muscarinic 2 ASTEMIZOLE Muscarinic M2 95% 1.409uM .501uM View
protein kinase C, alpha FAMOTIDINE Phorbol Ester 3% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 HALOPROGIN Serotonin Transporter 95% .811uM .431uM View
cholinergic receptor, muscarinic 1 DIPHENHYDRAMINE Muscarinic M1 95% .346uM .083uM View
cholinergic receptor, muscarinic 1 TRIHEXYPHENIDYL Muscarinic M1 95% .005608uM .001351uM View
cholinergic receptor, muscarinic 5 TRIHEXYPHENIDYL Muscarinic M5 95% .012uM .008679uM View
calcium channel, voltage-dependent, beta 1 subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 FLUPHENAZINE Serotonin Transporter 95% 1.492uM .793uM View
histamine receptor H 1 DOXEPIN Histamine H1, Central 95% .00057uM .000066uM View
adrenergic receptor, alpha 1d (Non-specific probe) DOXEPIN Adrenergic alpha1D 95% .118uM .058uM View
adrenergic receptor, alpha 2b DOXEPIN Adrenergic alpha2C 95% 1.029uM .15uM View
adrenergic receptor, alpha 2c (Non-specific probe) DOXEPIN Adrenergic alpha2C 95% 1.029uM .15uM View
Cytochrom P450-1A2 monooxygenase MOSAPRIDE CYP450-1A2 Inhibition 95% .4uM NoneNone View
adrenergic receptor, alpha 1b LABETALOL Adrenergic alpha1B 95% .583uM .323uM View
monoamine oxidase A GENISTEIN Monoamine Oxidase MAOA 95% 2.52uM NoneNone View
monoamine oxidase A GENISTEIN Monoamine Oxidase MAOA 95% 2.52uM NoneNone View
dopamine receptor 2 GENTIAN VIOLET Dopamine D2L 95% 3.178uM 1.059uM View
sodium channel, voltage-gated, type VII, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
amiloride-sensitive cation channel 5, intestinal DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type III, beta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type XI, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type I, beta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type V, alpha polypeptide DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type II, beta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, nonvoltage-gated 1 alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, nonvoltage-gated 1 gamma DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, nonvoltage-gated 1 beta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type XI, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, nonvoltage-gated 1, gamma DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, nonvoltage-gated 1, delta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, nonvoltage-gated 1 alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type X, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
5-hydroxytryptamine (serotonin) receptor 2B 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Serotonin 5-HT2B 94% .063uM .04uM View
adrenergic receptor, alpha 2a AMITRIPTYLINE Adrenergic alpha2A 94% .351uM .132uM View
adrenergic receptor, alpha 2b AMOXAPINE Adrenergic alpha2B 94% .558uM .255uM View
adrenergic receptor, alpha 2a CHLORPROMAZINE Adrenergic alpha2A 94% .352uM .132uM View
opioid receptor, sigma 1 CHLORPROMAZINE Sigma1 94% .451uM .189uM View
bradykinin receptor, beta 2 AMIODARONE Bradykinin B2 94% 12.966uM 7.674uM View
bradykinin receptor B2 AMIODARONE Bradykinin B2 94% 12.966uM 7.674uM View
calcium channel, voltage-dependent, gamma subunit 8 AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, gamma subunit 7 AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, gamma subunit 6 AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, gamma subunit 5 AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, gamma subunit 4 AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, gamma subunit 3 AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, gamma subunit 2 AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, gamma subunit 1 AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, beta 4 subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, beta 3 subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, beta 2 subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, alpha 1F subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, beta 1 subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 AMIODARONE Calcium Channel Type L, Phenylalkylamine 94% .539uM .524uM View
epidermal growth factor receptor COLISTIN Protein Tyrosine Kinase, EGF Receptor 94% 1.5uM NoneNone View
melanocortin 4 receptor COLISTIN Melanocortin MC4 94% .841uM .809uM View
dopamine receptor 2 DIHYDROERGOTAMINE Dopamine D2L 94% .00888uM .00296uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 TAMOXIFEN Adrenergic, Norepinephrine Transporter 94% 1.472uM 1.459uM View
opioid receptor, sigma 1 TAMOXIFEN Sigma1 94% .021uM .008714uM View
sodium channel, voltage-gated, type IV, beta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel associated protein 1 DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel associated protein 2 DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type III, beta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type I, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type IX, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type VII, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
amiloride-sensitive cation channel 5, intestinal DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, nonvoltage-gated 1, delta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, nonvoltage-gated 1 alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type X, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type IX, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage gated, type VIII, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type VII, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type IV, beta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type IV, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type III, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type II, beta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type II, alpha 2 TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type I, beta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type I, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type IV, beta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel associated protein 1 TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel associated protein 2 TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type III, beta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type I, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type IX, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type VII, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
amiloride-sensitive cation channel 5, intestinal TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type III, beta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type XI, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type I, beta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type 10, alpha polypeptide TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type IV, alpha polypeptide TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type V, alpha polypeptide TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type II, beta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, nonvoltage-gated 1 alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, nonvoltage-gated 1 gamma TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, nonvoltage-gated 1 beta TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PAROXETINE Dopamine Transporter 94% .672uM .534uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 METERGOLINE Adrenergic, Norepinephrine Transporter 94% .366uM .363uM View
adrenergic receptor, alpha 2b CINNARIZINE Adrenergic alpha2C 94% .652uM .095uM View
adrenergic receptor, alpha 2c (Non-specific probe) CINNARIZINE Adrenergic alpha2C 94% .652uM .095uM View
acetylcholinesterase (YT blood group) METERGOLINE Acetylcholinesterase 94% 1.344uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase METERGOLINE Acetylcholinesterase 94% 1.344uM NoneNone View
acetylcholinesterase METERGOLINE Acetylcholinesterase 94% 1.344uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 PROCHLORPERAZINE Adrenergic, Norepinephrine Transporter 94% .4uM .396uM View